Details for New Drug Application (NDA): 022315

✉ Email this page to a colleague

NDA 022315 describes OZURDEX, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. Additional details are available on the OZURDEX profile page.

The generic ingredient in OZURDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.

Summary for 022315

Tradename:	OZURDEX
Applicant:	Abbvie
Ingredient:	dexamethasone
Patents:	0

Pharmacology for NDA: 022315

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for 022315

Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents, Hormonal
Glucocorticoids

Suppliers and Packaging for NDA: 022315

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315	NDA	Allergan, Inc.	0023-3348	0023-3348-07	1 POUCH in 1 CARTON (0023-3348-07) / 1 IMPLANT in 1 POUCH
OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315	NDA	Allergan, Inc.	0023-3348	0023-3348-08	1 POUCH in 1 CARTON (0023-3348-08) / 1 IMPLANT in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	IMPLANT;INTRAVITREAL			Strength	0.7MG
Approval Date:	Jun 17, 2009	TE:		RLD:	Yes

Expired US Patents for NDA 022315

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315-001	Jun 17, 2009	⤷ Subscribe	⤷ Subscribe
Abbvie	OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315-001	Jun 17, 2009	⤷ Subscribe	⤷ Subscribe
Abbvie	OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315-001	Jun 17, 2009	⤷ Subscribe	⤷ Subscribe
Abbvie	OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315-001	Jun 17, 2009	⤷ Subscribe	⤷ Subscribe
Abbvie	OZURDEX	dexamethasone	IMPLANT;INTRAVITREAL	022315-001	Jun 17, 2009	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.